gc4702
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 26, 2016 (NCT03096756)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gc4702
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03096756 | Phase 1 | Jul 26, 2016 | Galera Therapeutics, INC Research, Nucleus Network Ltd |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Galera Therapeutics | For profit | 1 | 1 | 1 | 2016 |
| INC Research | For profit | 1 | 0 | 1 | 2016 |
| Nucleus Network Ltd | For profit | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1